How AI is speeding development of COVID-19 therapies
Published: April 2, 2020
01st April 2020 – Written by Dr Ulrik Kristensen, featured on The Science Advisory Board Website – Drug discovery is a notoriously long, complex, and expensive process requiring the concerted efforts of the world’s brightest minds. As the world is facing a new challenge in trying to both adapt to and defend itself against the novel coronavirus, artificial intelligence (AI) is offering new hope that a cure might be developed faster than ever before.
In fact, startups focusing on the use of AI in drug design and development have seen significant investment of around $5.2 billion in recent years.
Click here to continue reading on The Science Advisory Board’s website…Share on LinkedIn
AI in Drug Development & Clinical TrialsPublished December 2020.
AI in Drug Development & Clinical Trials
This is a brochure for Signify Research’s 2020 report on the global market for AI in drug development & clinical trials published in December 2020.
Find out more